Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Report: Biopharma, other IP-intensive sectors add $5 trillion to US economy

This article was originally published in Scrip

Executive Summary

While all US industries either produce or use intellectual property (IP) to some degree, the 75 sectors that rely most intensively on IP, which includes biopharmaceutical manufacturers, generate more than one-third of the US gross domestic product (GDP) – contributing about $5 trillion to the nation's economy, the Obama administration reported on 11 April in a first-of-its-kind analysis.

Advertisement
Advertisement
UsernamePublicRestriction

Register

SC016953

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel